Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Tempest Therapeutics, Inc. (TPST) Debt to Equity Ratio data is not available for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-26.26M |
|
-- |
|
-- |
|
$26.57M |
|
$-26.57M |
|
$0.31M |
|
$-26.26M |
|
$-26.26M |
|
$-26.26M |
|
$-26.26M |
|
$-26.26M |
|
$-26.26M |
|
$-26.57M |
|
$-26.31M |
|
4.15M |
|
4.15M |
|
$-6.33 |
|
$-6.33 |
|
| Balance Sheet Financials | |
$8.27M |
|
$0.60M |
|
$8.66M |
|
$16.93M |
|
$3.31M |
|
-- |
|
$6.95M |
|
$10.26M |
|
$6.67M |
|
$6.67M |
|
$6.67M |
|
4.93M |
|
| Cash Flow Statement Financials | |
$-26.82M |
|
-- |
|
$4.26M |
|
$30.71M |
|
$8.15M |
|
$-22.56M |
|
$3.12M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.50 |
|
-- |
|
-- |
|
-- |
|
|
Debt to Equity Ratio |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-26.82M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-393.85% |
|
-393.85% |
|
-155.11% |
|
-393.85% |
|
$1.35 |
|
$-6.46 |
|
$-6.46 |
|